Clinical trial

A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in…

NCT00001428 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00001428
Title A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer
Official title A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Colorectal Neoplasms
Intervention type Drug
Interventions 5-fluorouracil
Enrollment 65
Start date Feb 1, 1995
Completion Dec 1, 2000
First posted Dec 10, 2002
Last update posted Mar 4, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies